510(k) Report

510(k) · Cleared

Cleared

Topcon 3D Oct-1000 Optical Coherence Tomography System

K063388510(k) TraditionalCleared Jun 22, 2007226-day reviewClass II21 CFR 886.1570

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Topcon Corp. · OBO Tomography, Optical Coherence

Cleared on Jun 22, 2007 after a 226-day review. The FDA summary names its predicate without a number. 41 later devices descend from it.

Decided
Jun 22, 2007
Review
226 days
Class
Class II
Product code
OBO
Recalls
None
Predicates
0

41 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2009: 4 descendants cleared2012: 2 descendants cleared2013: 3 descendants cleared2011: 1 descendant cleared2019: 1 descendant cleared2014: 3 descendants cleared2015: 3 descendants cleared2022: 3 descendants cleared2018: 6 descendants cleared2020: 3 descendants cleared2017: 2 descendants cleared2024: 2 descendants cleared2023: 5 descendants cleared2021: 1 descendant cleared2026: 2 descendants cleared20052010201520202025
  1. This deviceK063388 Topcon 3D Oct-1000 Optical Coherence Tomography SystemTopcon Corp. · 2007
  2. Descendant · cites it directly · 39 of its ownK072971 Topcon 3D Oct-1000 Optical Coherence Tomography System for…Topcon Medical Systems, Inc. · 2009
  3. Descendant · 2 generations on · 29 of its ownK093313 SynergyTopcon Medical Systems, Inc. · 2009
  4. Descendant · 3 generations on · 25 of its ownK122938 Forum Forum Archive Forum Archive & Viewer Forum Assist MatchCarl Zeiss Meditec, AG · 2012 · Recalled
  5. Descendant · cites it directly · 15 of its ownK083316 3D Oct-1000 Mark II Optical Coherence Tomography SystemTopcon Medical Systems, Inc. · 2009
  6. Descendant · 2 generations on · 14 of its ownK092470 Optical Coherence Tomography 3D Oct-2000Topcon Corp. · 2009

Showing 5 of 41 descendants. See all descendants

Descendants cleared per year

2009: 42011: 12012: 22013: 32014: 32015: 32017: 22018: 62019: 12020: 32021: 12022: 32023: 52024: 22026: 2
2009high 6 (2018) · low 0 (2010)2026

Most influential descendants

Showing 5 of 41 · See all
  • K072971Topcon 3D Oct-1000 Optical Coherence Tomography System for Measurement of Retinal…Topcon Medical Systems, Inc. · 2009 · cites it directly39descendants
  • K093313SynergyTopcon Medical Systems, Inc. · 2009 · 2 generations on29descendants
  • K122938Forum Forum Archive Forum Archive & Viewer Forum Assist MatchCarl Zeiss Meditec, AG · 2012 · 3 generations on25descendants
  • K0833163D Oct-1000 Mark II Optical Coherence Tomography SystemTopcon Medical Systems, Inc. · 2009 · cites it directly15descendants
  • K092470Optical Coherence Tomography 3D Oct-2000Topcon Corp. · 2009 · 2 generations on14descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K063388Topcon 3D Oct-1000 Optical Coherence Tomography SystemTopcon Corp.2007—
+1K072971Topcon 3D Oct-1000 Optical Coherence Tomography System for Measurement of…Topcon Medical Systems, Inc.2009—
+2K093313SynergyTopcon Medical Systems, Inc.2009—
+3K122938Forum Forum Archive Forum Archive & Viewer Forum Assist MatchCarl Zeiss Meditec, AG20121
+1K0833163D Oct-1000 Mark II Optical Coherence Tomography SystemTopcon Medical Systems, Inc.2009—
+2K092470Optical Coherence Tomography 3D Oct-2000Topcon Corp.2009—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200940
201110
201220
201330
201430
201530
201720
201860
201910
202030
202110
202230
202350
202420
202620
FIG. 1 — Lineage of K063388, 2007–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OBO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OBO device

  1. #1 K250868 SPECTRALIS HRA+OCT and variantsscore 16.2 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Carl Zeiss, Inc., Humphrey OCT Scanner
Named without a submission number
—
*—Carl Zeiss Ophthalmic Systems, Inc.'s, Humphrey OCT 3
Named without a submission number
—

What descends from it? (41)

See all 41

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K072971Topcon 3D Oct-1000 Optical Coherence Tomography System for Measurement of Retinal…Topcon Medical Systems, Inc.200939
K0833163D Oct-1000 Mark II Optical Coherence Tomography SystemTopcon Medical Systems, Inc.200915

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K072971 (Topcon Medical Systems, Inc., 2009) has gone furthest, with 39 descendants of its own.

How does its category compare?

All OBO devices

OBO Tomography, Optical Coherence: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · OBO

3in 2025

2007: 22008: 22009: 42010: 22011: 22012: 32013: 22014: 32015: 12016: 42017: 42018: 62019: 52020: 22021: 12022: 22023: 72024: 82025: 32026 (partial year): 2
2007high 8 (2024) · low 1 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OBO

125in 2025

2009: 151 days median2012: 269 days median2014: 152 days median2016: 125 days median2017: 118 days median2018: 87 days median2019: 249 days median2023: 262 days median2024: 157 days median2025: 125 days median
2007high 269 (2012) · low 87 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OBO

1in 2022

2010: 12011: 22012: 22018: 12021: 12022: 12026 (partial year): 1
2007high 2 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OBO

4in 2025

2013: 22016: 12018: 12021: 12023: 32024: 32025: 4
2007high 4 (2025) · low 0 (2007)2025

MAUDE reports naming product code OBO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20082—00
2009415100
20102—10
20112—20
2012326920
20132—02
2014315200
20151—00
2016412501
2017411800
201868711
2019524900
20202—00
20211—11
20222—10
2023726203
2024815703
2025312504
20262—1—

What is it indicated for?

The Topcon 3D OCT-1000 is a non-contact ophthalmic imaging system for the viewing and axial cross sectional imaging of posterior ocular structures. It is used for in vivo imaging of the retina, retinal nerve fiber layer and optic disc. It is intended for use as a diagnostic device to aid in the detection and management of ocular diseases, including but not limited to macular edema and central serous retinopathy.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K063388: Topcon 3D Oct-1000 Optical Coherence Tomography System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K063388

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026